Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: Prostate. 2017 Nov 6;78(2):121–127. doi: 10.1002/pros.23452

Table 3.

Correlation of Baseline miRNAs (CTs) with 28-week PSA Response Categories for All Prespecified miRNA measures and Exploratory miRNA with p< 0.10

miRNA Median miRNA value for Each PSA response group p-value*
PSA ≤ 0.2 0.2< PSA≤4.0 PSA > 4.0 ng/ml
miR-141 32.6 32.0 31.5 0.06
miR-200a 34.5 33.8 33.8 0.32
miR-200b 33.6 33.6 32.6 0.005
miR-210 32.5 32.1 32.3 0.59
miR-375 33.0 32.6 29.5 0.001
Additional exploratory miRNA candidates
hsa-miR-505 32.1 32.6 31.9 0.004
hsa-miR-136 32.3 30.5 32.9 0.009
hsa-miR-204 34.6 36.2 35.0 0.02
hsa-miR-99a 32.7 34.6 32.4 0.02
hsa-miR-130a 32.3 31.4 31.7 0.02
hsa-miR-10a 35.3 37.4 35.6 0.03
hsa-miR-450a 35.9 39.6 36.8 0.03
hsa-miR-376b 30.8 29.5 31.5 0.03
hsa-miR-376c 30.7 29.1 31.4 0.034
hsa-miR-431 33.4 31.8 33.8 0.04
hsa-miR-381 35.5 34.3 36.3 0.04
hsa-miR-671-5p 34.8 34.3 33.5 0.05
hsa-miR-376a 32.4 30.7 32.4 0.05
hsa-miR-411 33.8 33.3 34.9 0.05
hsa-miR-125b 31.4 31.6 31.1 0.06
hsa-miR-370 34.3 32.9 34.3 0.06
hsa-miR-127-3p 31.6 30.3 32.1 0.06
*

Based on 2 degree of freedom chisquare, Friedman test